The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Treatment of de novo bifurcation lesions: comparison of Sirolimus- and Paclitaxel-eluting stents

EuroIntervention 2005;1:24-30 - DOI10.4244/EIJV1I1A01.

Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands

Objective: Both the sirolimus-(SES) and paclitaxel-eluting (PES) stents have been shown to reduce restenosis rates when used in relatively simple lesions. This study aimed to evaluate the results of a consecutive

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

Influence of technical strategies on the outcome of coronary bifurcation stenting

Latest news